Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.3058 | 0.5 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0073 | 0.5834 | 0.5 |
Brugia malayi | Bromodomain containing protein | 0.0111 | 0.9288 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0073 | 0.5834 | 0.5767 |
Brugia malayi | hypothetical protein | 0.0043 | 0.3058 | 0.3178 |
Schistosoma mansoni | bromodomain-containing nuclear protein 1 brd1 | 0.0108 | 0.9023 | 1 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0029 | 0.1748 | 0.3555 |
Giardia lamblia | PHD finger protein 15 | 0.0029 | 0.1748 | 0.5 |
Brugia malayi | PHD-finger family protein | 0.0029 | 0.1748 | 0.1743 |
Schistosoma mansoni | nuclear receptor 2DBD-gamma | 0.0012 | 0.0156 | 0.0173 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0073 | 0.5834 | 0.5767 |
Echinococcus multilocularis | enhancer of polycomb | 0.0018 | 0.0687 | 0.0539 |
Schistosoma mansoni | thyroid hormone receptor | 0.0012 | 0.0156 | 0.0173 |
Schistosoma mansoni | enhancer of polycomb | 0.0018 | 0.0687 | 0.0762 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.5834 | 0.6465 |
Schistosoma mansoni | RAR-like nuclear receptor | 0.0012 | 0.0156 | 0.0173 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.3058 | 0.3389 |
Schistosoma mansoni | enhancer of polycomb | 0.0018 | 0.0687 | 0.0762 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.002 | 0.0857 | 0.1565 |
Echinococcus granulosus | enhancer of polycomb | 0.0018 | 0.0687 | 0.0539 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.3058 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.3058 | 0.2948 |
Echinococcus granulosus | enhancer of polycomb | 0.0018 | 0.0687 | 0.0539 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.3058 | 0.5 |
Schistosoma mansoni | photoreceptor-specific nuclear receptor related | 0.0012 | 0.0156 | 0.0173 |
Plasmodium falciparum | phd finger protein, putative | 0.0029 | 0.1748 | 0.5 |
Schistosoma mansoni | steroid hormone receptor ad4bp | 0.0012 | 0.0156 | 0.0173 |
Schistosoma mansoni | coup transcription factor | 0.0012 | 0.0156 | 0.0173 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.3058 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.5834 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.1748 | 0.3555 |
Schistosoma mansoni | enhancer of polycomb | 0.0018 | 0.0687 | 0.0762 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.4633 | 1 |
Brugia malayi | jmjC domain containing protein | 0.002 | 0.0857 | 0.0767 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0.5834 | 1 |
Schistosoma mansoni | nuclear hormone receptor nor-1/nor-2 | 0.0012 | 0.0156 | 0.0173 |
Schistosoma mansoni | Tr4/Tr2 (homologue) | 0.0012 | 0.0156 | 0.0173 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.5834 | 0.5 |
Echinococcus multilocularis | peregrin | 0.0118 | 1 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.3058 | 0.2948 |
Echinococcus granulosus | PHD finger protein rhinoceros | 0.0029 | 0.1748 | 0.1617 |
Schistosoma mansoni | thyroid hormone receptor | 0.0012 | 0.0156 | 0.0173 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.002 | 0.0857 | 0.0712 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.3058 | 0.3389 |
Trichomonas vaginalis | conserved hypothetical protein | 0.006 | 0.4633 | 0.5 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0012 | 0.0156 | 0.0173 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.5834 | 0.6465 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.0012 | 0.0156 | 0.0173 |
Schistosoma mansoni | FTZ-F1 nuclear receptor-like protein | 0.0012 | 0.0156 | 0.0173 |
Plasmodium vivax | hypothetical protein, conserved | 0.0029 | 0.1748 | 0.5 |
Schistosoma mansoni | enhancer of polycomb | 0.0018 | 0.0687 | 0.0762 |
Echinococcus multilocularis | PHD finger protein rhinoceros | 0.0029 | 0.1748 | 0.1617 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0073 | 0.5834 | 0.5 |
Onchocerca volvulus | Alhambra homolog | 0.0029 | 0.1748 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.5834 | 0.5 |
Echinococcus multilocularis | enhancer of polycomb | 0.0018 | 0.0687 | 0.0539 |
Schistosoma mansoni | nuclear hormone receptor | 0.0012 | 0.0156 | 0.0173 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.002 | 0.0857 | 0.0712 |
Schistosoma mansoni | hypothetical protein | 0.0029 | 0.1748 | 0.1937 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.5623 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 2.2387 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 8.2753 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 10.3225 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 100 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.